Berry Street and Healthify combine to expand GLP-1 nutrition services
U.S. nutrition company Berry Street has merged with India's Healthify to tap into the rising demand for GLP-1 weight-loss treatments. The founders of both firms will serve as co-CEOs, with Berry Street operating in the U.S. and Healthify in other markets. Healthify claims over 45 million customers served, while Berry Street brings a network of 2,000 clinics and insurance-covered GLP-1 care.
The merger unites two companies with complementary strengths in the weight-loss and nutrition technology space. Healthify brings its AI-driven coaching platform and a claimed customer base of over 45 million, while Berry Street contributes a clinical network of more than 2,000 U.S. clinics and established insurance coverage for GLP-1 treatments. The combined entity will be led by both founders, with Berry Street's brand retained for the U.S. market and Healthify's brand used internationally.
The deal comes amid projections that over 30 million Americans will use GLP-1 drugs by 2030. Healthify has raised more than $150 million in funding, while Berry Street secured $50 million last year from investors including Northzone and Sofina. Berry Street reports having served over 200,000 people through partnerships with Amazon and Walmart, and Healthify expanded into the U.S. market last year.
This merger could reshape how GLP-1 weight-loss treatments are delivered, potentially making them more accessible through insurance-covered clinical networks combined with AI-powered coaching. Patients may benefit from more integrated care that addresses nutrition alongside medication, which could improve long-term outcomes. However, the consolidation of two major players may also concentrate market power in metabolic health services, potentially affecting pricing and competition. The success of this model could influence how other startups approach the growing demand for weight-management solutions.